These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 8018659

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells.
    Lo HM, Hung CF, Tseng YL, Chen BH, Jian JS, Wu WB.
    Biochem Pharmacol; 2007 Jun 30; 74(1):54-63. PubMed ID: 17449016
    [Abstract] [Full Text] [Related]

  • 3. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty.
    Nili N, Cheema AN, Giordano FJ, Barolet AW, Babaei S, Hickey R, Eskandarian MR, Smeets M, Butany J, Pasterkamp G, Strauss BH.
    Am J Pathol; 2003 Sep 30; 163(3):869-78. PubMed ID: 12937128
    [Abstract] [Full Text] [Related]

  • 4. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor.
    Facchiano A, De Marchis F, Turchetti E, Facchiano F, Guglielmi M, Denaro A, Palumbo R, Scoccianti M, Capogrossi MC.
    J Cell Sci; 2000 Aug 30; 113 ( Pt 16)():2855-63. PubMed ID: 10910770
    [Abstract] [Full Text] [Related]

  • 5. Effect of transforming growth factor-beta 1 on platelet-derived growth factor receptor binding and gene expression in vascular smooth muscle cells from SHR and WKY rats.
    Agrotis A, Saltis J, Bobik A.
    Clin Exp Pharmacol Physiol; 1994 Feb 30; 21(2):145-8. PubMed ID: 7518757
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF.
    Chen CP, Hung CF, Lee SC, Lo HM, Wu PH, Wu WB.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 May 30; 381(5):401-14. PubMed ID: 20237770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor.
    Rutherford C, Martin W, Salame M, Carrier M, Anggård E, Ferns G.
    Atherosclerosis; 1997 Apr 30; 130(1-2):45-51. PubMed ID: 9126647
    [Abstract] [Full Text] [Related]

  • 10. Smooth muscle cells isolated from the neointima after vascular injury exhibit altered responses to platelet-derived growth factor and other stimuli.
    Majack RA, Grieshaber NA, Cook CL, Weiser MC, McFall RC, Grieshaber SS, Reidy MA, Reilly CF.
    J Cell Physiol; 1996 Apr 30; 167(1):106-12. PubMed ID: 8698827
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell.
    Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y.
    Circulation; 2002 Jun 18; 105(24):2893-8. PubMed ID: 12070119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors.
    Watanabe S, Matsuda A, Suzuki Y, Kondo K, Ikeda Y, Hashimoto H, Umemura K.
    Br J Pharmacol; 2000 May 18; 130(2):307-14. PubMed ID: 10807667
    [Abstract] [Full Text] [Related]

  • 15. Platelet surface membranes are highly mitogenic for coronary artery smooth muscle cells--A novel mechanism for sustained proliferation after vessel injury?
    Weber AA, Zucker TP, Schrör K.
    Biochem Biophys Res Commun; 1999 Jun 07; 259(2):341-3. PubMed ID: 10362510
    [Abstract] [Full Text] [Related]

  • 16. Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation.
    Spacey GD, Uings IJ, Slater M, Hirst S, Bonser RW.
    Biochem Pharmacol; 1998 Feb 01; 55(3):261-71. PubMed ID: 9484791
    [Abstract] [Full Text] [Related]

  • 17. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty.
    Wang X, Louden C, Ohlstein EH, Stadel JM, Gu JL, Yue TL.
    Arterioscler Thromb Vasc Biol; 1996 Nov 01; 16(11):1365-72. PubMed ID: 8911275
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.
    Wong J, Rauhöft C, Dilley RJ, Agrotis A, Jennings GL, Bobik A.
    Circulation; 1997 Sep 02; 96(5):1631-40. PubMed ID: 9315558
    [Abstract] [Full Text] [Related]

  • 19. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J, Uecker A, Kroll J, Frank H, Mayr U, Bjorge JD, Fujita D, Gazit A, Hombach V, Levitzki A, Böhmer FD.
    Circ Res; 1999 Jul 09; 85(1):12-22. PubMed ID: 10400906
    [Abstract] [Full Text] [Related]

  • 20. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis.
    Yamasaki Y, Miyoshi K, Oda N, Watanabe M, Miyake H, Chan J, Wang X, Sun L, Tang C, McMahon G, Lipson KE.
    Circ Res; 2001 Mar 30; 88(6):630-6. PubMed ID: 11282898
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.